Binx Health

Binx is a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study and shop.

Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most.

Binx Health was founded in 2005 by John Clarkson and Pavel Rodyukov. The company is headquartered in Boston, Massachusetts and Bath UK.

 

Binx works with large corporate partners and institutions who have access large patient populations and have a significant interest in delivering or facilitating better healthcare to provide access to and enable more streamlined delivery of diagnostic testing and care.

 

Binx's io® platform is designed to offer rapid PCR-based results, up to 24-plex, from sample-in-to-answer in about 30 minutes, greatly accelerating today’s multiple day standard-of-care central lab testing paradigm.

Binx's omnichannel platform includes the point-of-care io platform which puts central-lab quality testing solutions in the hands of clinicians everywhere.

Binx's 'Everywhere Care' business model is premised on the view that testing solutions for many diseases and disorders are needed in both traditional healthcare delivery locations and through remote and at-home access, to truly provide better access in support of total population health.

 

Binx is backed by OrbiMed, Arrowmark Partners, JJDC, Hildred Capital Management, Novartis Venture Fund, LSP, Alta Life Sciences, Innovate UK and others. The company raised $104M in Series E round on May 27, 2021. This brings Binx's total funding to $219.7M to date.

 

 

  • Year founded: 2005
  • Funding Info: $219.7M over 7 Rounds (Latest Funding Type: Series E)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Boston
  • State: Massachusetts
  • Country: United States
Related businesses